| Do Drugs vs Jin | 24–7 | 77.42% |
| Do Drugs vs Kazuya | 19–7 | 73.08% |
| Do Drugs vs King | 16–9 | 64.00% |
| Do Drugs vs Bryan | 15–5 | 75.00% |
| Do Drugs vs Leo | 13–7 | 65.00% |
| Do Drugs vs Reina | 16–4 | 80.00% |
| Do Drugs vs Eddy | 13–6 | 68.42% |
| Do Drugs vs Law | 9–6 | 60.00% |
| Do Drugs vs Yoshimitsu | 12–2 | 85.71% |
| Do Drugs vs Xiaoyu | 10–2 | 83.33% |
| Do Drugs vs Feng | 9–2 | 81.82% |
| Do Drugs vs Dragunov | 8–3 | 72.73% |
| Do Drugs vs Fahkumram | 9–2 | 81.82% |
| Do Drugs vs Jack-8 | 10–0 | 100.00% |
| Do Drugs vs Lee | 7–3 | 70.00% |
| Do Drugs vs Claudio | 5–4 | 55.56% |
| Do Drugs vs Steve | 4–4 | 50.00% |
| Do Drugs vs Lili | 5–3 | 62.50% |
| Do Drugs vs Jun | 3–5 | 37.50% |
| Do Drugs vs Asuka | 6–1 | 85.71% |
| Do Drugs vs Devil Jin | 4–3 | 57.14% |
| Do Drugs vs Alisa | 4–3 | 57.14% |
| Do Drugs vs Nina | 5–2 | 71.43% |
| Do Drugs vs Lars | 6–0 | 100.00% |
| Do Drugs vs Victor | 3–3 | 50.00% |
| Do Drugs vs Paul | 5–0 | 100.00% |
| Do Drugs vs Panda | 4–1 | 80.00% |
| Do Drugs vs Leroy | 1–3 | 25.00% |
| Do Drugs vs Azucena | 3–1 | 75.00% |
| Do Drugs vs Hwoarang | 3–0 | 100.00% |
| Do Drugs vs Raven | 1–2 | 33.33% |
| Do Drugs vs Heihachi | 1–2 | 33.33% |
| Do Drugs vs Anna | 2–1 | 66.67% |
| Do Drugs vs Shaheen | 2–0 | 100.00% |
| Do Drugs vs Zafina | 1–0 | 100.00% |
| Do Drugs vs Clive | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.